Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

This study was conducted to assess whether levetiracetam (LEV) affects the survival of patients with glioblastoma (GBM) treated with concurrent temozolomide (TMZ) chemotherapy. To this end, from 2004 to 2016, 322 patients with surgically resected and pathologically confirmed isocitrate dehydrogenase...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Tae Hoon, Moon, Ju Hyung, Park, Hun Ho, Kim, Eui Hyun, Hong, Chang-Ki, Kim, Se Hoon, Kang, Seok-Gu, Chang, Jong Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330022/
https://www.ncbi.nlm.nih.gov/pubmed/32612203
http://dx.doi.org/10.1038/s41598-020-67697-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330022/
https://www.ncbi.nlm.nih.gov/pubmed/32612203
http://dx.doi.org/10.1038/s41598-020-67697-w

Ejemplares similares